Peanut Allergy Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035
The global peanut allergy market is evolving rapidly as the focus shifts from avoidance and rescue medication to disease-modifying therapies. The introduction of oral immunotherapy represents a paradigm shift in treatment, helping patients develop desensitization and reduce the severity of allergic reactions. Rising allergy prevalence, improved diagnostic practices, and strong awareness campaigns are accelerating early intervention and physician adoption. The market’s future growth will hinge on innovation in delivery methods, safety, and patient adherence.
Impact
Demand – Drivers and Limitations
The following are the drivers for the global peanut allergy market:
Product/Innovation Strategy: This report identifies key growth opportunities across oral, epicutaneous, and biologic therapies while analyzing regulatory trends and emerging technologies. It helps organizations refine product pipelines, prioritize innovation in safety and delivery, and align R&D efforts with expanding pediatric and global market needs.
Competitive Strategy: The report offers an in-depth competitor landscape, highlighting strategies of leading players. It benchmarks pricing, pipeline maturity, and partnership models to support market-entry and portfolio optimization decisions. Insights on regional expansion, payer engagement, and lifecycle management provide actionable direction for sustaining competitive advantage.
Key Market Players and Competition Synopsis
Market competition centers on formulation innovation, patient convenience, and regional market access. Strategic collaborations, global commercialization alliances, and pipeline differentiation will define leadership over the next decade.
Some of the prominent names established in this market are:
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
This report will be delivered in 7-10 working days.
Impact
- Increasing demand for peanut allergy therapies is anticipated to support the growth of the global peanut allergy market during the forecast period 2025-2035.
- The global peanut allergy market is expected to grow at a significant rate due to advancements in treatment, the development of innovative therapies, and increasing drug approvals of the treatment of peanut allergy.
Demand – Drivers and Limitations
The following are the drivers for the global peanut allergy market:
- Shift Toward Disease-Modifying Therapies: Approval of PALFORZIA and Xolair signals a major transition from avoidance-only management to proactive desensitization.
- Increased Diagnosis and Awareness: Broader allergy testing, physician training, and public health initiatives are improving diagnosis rates and patient engagement.
- Innovation in Drug Delivery and Safety: Novel platforms such as epicutaneous patches and oral mucosal therapies are addressing adherence and safety limitations of traditional OIT approaches.
- High Therapy Costs and Limited Reimbursement: The premium pricing of biologics and immunotherapies limits accessibility in markets with minimal insurance coverage.
- Adverse Events and Compliance Challenges: Risks of allergic reactions during treatment and the need for strict dosing schedules may hinder adoption.
Product/Innovation Strategy: This report identifies key growth opportunities across oral, epicutaneous, and biologic therapies while analyzing regulatory trends and emerging technologies. It helps organizations refine product pipelines, prioritize innovation in safety and delivery, and align R&D efforts with expanding pediatric and global market needs.
Competitive Strategy: The report offers an in-depth competitor landscape, highlighting strategies of leading players. It benchmarks pricing, pipeline maturity, and partnership models to support market-entry and portfolio optimization decisions. Insights on regional expansion, payer engagement, and lifecycle management provide actionable direction for sustaining competitive advantage.
Key Market Players and Competition Synopsis
Market competition centers on formulation innovation, patient convenience, and regional market access. Strategic collaborations, global commercialization alliances, and pipeline differentiation will define leadership over the next decade.
Some of the prominent names established in this market are:
- Stallergenes Greer
- F. Hoffmann-La Roche Ltd
- Novartis, AG
- Cambridge Allergy Ltd
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
This report will be delivered in 7-10 working days.
Executive Summary
Scope and Definition
Market/Product Definition
Key Questions Answered
Analysis and Forecast Note
1. GLOBAL PEANUT ALLERGY MARKET: INDUSTRY OUTLOOK
1.1 Market Overview
1.2 Clinical Trials
1.3 Regulatory Landscape / Compliance
1.4 Key Trends
1.5 Market Dynamics
1.5.1 Impact Analysis
1.5.2 Market Drivers
1.5.3 Market Restraints
1.5.4 Market Opportunities
2. GLOBAL PEANUT ALLERGY MARKET, BY REGION, $MILLION, 2023-2035
2.1 North America
2.1.1 Market Dynamics
2.1.2 Market Sizing and Forecast
2.1.2.1 North America Peanut Allergy Market, by Country
2.1.2.1.1 U.S.
2.2 Europe
2.2.1 Market Dynamics
2.2.2 Market Sizing and Forecast
2.2.2.1 Europe Peanut Allergy Market, by Country
2.2.2.1.1 Germany
2.2.2.1.2 U.K.
2.2.2.1.3 France
2.2.2.1.4 Italy
2.2.2.1.5 Spain
2.3 Asia-Pacific
2.3.1 Market Dynamics
2.3.2 Market Sizing and Forecast
2.3.2.1 Asia-Pacific Peanut Allergy Market, by Country
2.3.2.1.1 Japan
3. GLOBAL PEANUT ALLERGY MARKET: COMPETITIVE LANDSCAPE AND COMPANY PROFILES
3.1 Key Developments and Strategies
3.1.1 Funding Activities
3.1.2 Mergers and Acquisitions
3.1.3 Regulatory Approvals
3.1.4 Partnerships, Collaborations, and Business Expansions
3.2 Company Profiles
3.2.1 Stallergenes Greer
3.2.1.1 Overview
3.2.1.2 Product Portfolio
3.2.1.3 Target Customers
3.2.1.4 Key Personnel
3.2.1.5 Analyst View
3.2.2 F. Hoffmann-La Roche Ltd. (Genentech, Inc)
3.2.2.1 Overview
3.2.2.2 Product Portfolio
3.2.2.3 Target Customers
3.2.2.4 Key Personnel
3.2.2.5 Analyst View
3.2.3 Novartis, AG
3.2.3.1 Overview
3.2.3.2 Product Portfolio
3.2.3.3 Target Customers
3.2.3.4 Key Personnel
3.2.3.5 Analyst View
3.2.4 Cambridge Allergy Ltd
3.2.4.1 Overview
3.2.4.2 Product Portfolio
3.2.4.3 Target Customers
3.2.4.4 Key Personnel
3.2.4.5 Analyst View
3.2.5 Others
4. RESEARCH METHODOLOGY
Scope and Definition
Market/Product Definition
Key Questions Answered
Analysis and Forecast Note
1. GLOBAL PEANUT ALLERGY MARKET: INDUSTRY OUTLOOK
1.1 Market Overview
1.2 Clinical Trials
1.3 Regulatory Landscape / Compliance
1.4 Key Trends
1.5 Market Dynamics
1.5.1 Impact Analysis
1.5.2 Market Drivers
1.5.3 Market Restraints
1.5.4 Market Opportunities
2. GLOBAL PEANUT ALLERGY MARKET, BY REGION, $MILLION, 2023-2035
2.1 North America
2.1.1 Market Dynamics
2.1.2 Market Sizing and Forecast
2.1.2.1 North America Peanut Allergy Market, by Country
2.1.2.1.1 U.S.
2.2 Europe
2.2.1 Market Dynamics
2.2.2 Market Sizing and Forecast
2.2.2.1 Europe Peanut Allergy Market, by Country
2.2.2.1.1 Germany
2.2.2.1.2 U.K.
2.2.2.1.3 France
2.2.2.1.4 Italy
2.2.2.1.5 Spain
2.3 Asia-Pacific
2.3.1 Market Dynamics
2.3.2 Market Sizing and Forecast
2.3.2.1 Asia-Pacific Peanut Allergy Market, by Country
2.3.2.1.1 Japan
3. GLOBAL PEANUT ALLERGY MARKET: COMPETITIVE LANDSCAPE AND COMPANY PROFILES
3.1 Key Developments and Strategies
3.1.1 Funding Activities
3.1.2 Mergers and Acquisitions
3.1.3 Regulatory Approvals
3.1.4 Partnerships, Collaborations, and Business Expansions
3.2 Company Profiles
3.2.1 Stallergenes Greer
3.2.1.1 Overview
3.2.1.2 Product Portfolio
3.2.1.3 Target Customers
3.2.1.4 Key Personnel
3.2.1.5 Analyst View
3.2.2 F. Hoffmann-La Roche Ltd. (Genentech, Inc)
3.2.2.1 Overview
3.2.2.2 Product Portfolio
3.2.2.3 Target Customers
3.2.2.4 Key Personnel
3.2.2.5 Analyst View
3.2.3 Novartis, AG
3.2.3.1 Overview
3.2.3.2 Product Portfolio
3.2.3.3 Target Customers
3.2.3.4 Key Personnel
3.2.3.5 Analyst View
3.2.4 Cambridge Allergy Ltd
3.2.4.1 Overview
3.2.4.2 Product Portfolio
3.2.4.3 Target Customers
3.2.4.4 Key Personnel
3.2.4.5 Analyst View
3.2.5 Others
4. RESEARCH METHODOLOGY
LIST OF FIGURES
Figure: Peanut Allergy Market (by Scenario), $Million, 2024, 2030, and 2035
Figure: Global Peanut Allergy Market, 2024 and 2035
Figure: Global Peanut Allergy Market Key Trends, Impact Analysis, 2023-2035
Figure: North America Peanut Allergy Market, $Million, 2023-2035
Figure: Europe Peanut Allergy Market, $Million, 2023-2035
Figure: Asia-Pacific Peanut Allergy Market, $Million, 2023-2035
Figure: Peanut Allergy Market (by Scenario), $Million, 2024, 2030, and 2035
Figure: Global Peanut Allergy Market, 2024 and 2035
Figure: Global Peanut Allergy Market Key Trends, Impact Analysis, 2023-2035
Figure: North America Peanut Allergy Market, $Million, 2023-2035
Figure: Europe Peanut Allergy Market, $Million, 2023-2035
Figure: Asia-Pacific Peanut Allergy Market, $Million, 2023-2035
LIST OF TABLES
Table: Market Snapshot
Table: Market Dynamics
Table: Global Peanut Allergy Market (by Region), $Million, 2023-2035
Table: Market Snapshot
Table: Market Dynamics
Table: Global Peanut Allergy Market (by Region), $Million, 2023-2035
